Differences in mean pill count adherence rates by study arm at each assessment point during the 24-week intervention period, stratified by baseline viral load (≥75 copies/ml versus <75 copes/ml). Precise estimates available in online supplementary materials.
DOT: directly observed therapy; TAU: treatment as usual; VL: viral load
*p < 0.01 for difference between DOT and TAU among participants with undetectable baseline VL.
†p < 0.01 for difference between DOT and TAU among participants with detectable baseline VL.
All p values based on mixed effects model analysis.